martes, 9 de noviembre de 2021

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19 | Infectious Diseases | JAMA Network Open | JAMA Network

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19 | Infectious Diseases | JAMA Network Open | JAMA Network

No hay comentarios:

Publicar un comentario